Comparison of contrast-enhanced ultrasonography with grey-scale ultrasonography and contrast-enhanced computed tomography in diagnosing focal fatty liver infiltrations and focal fatty sparing

Advances in Medical Sciences

Volumn 58, Issue 2, 2013, Pages 408-418

  Janica, J ^a   Ustymowicz, A ^a   Lukasiewicz, A ^a   Panasiuk, A ^a   Niemcunowicz Janica, A ^a   Turecka Kulesza, E ^a   Lebkowska, U ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Contrast enhanced computed tomography; Contrast enhanced ultrasonography; Focal fatty liver infiltrations; Focal fatty sparing

Indexed keywords

IOMEPROL; SONOVUE;

ADULT; AGED; ARTICLE; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; ECHOGRAPHY; FATTY LIVER; FEMALE; FOCAL FATTY LIVER INFILTRATION; FOCAL FATTY SPARING; HUMAN; LIVER PARENCHYMA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTIVE VALUE; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CONTRAST MEDIA; FATTY LIVER; FEMALE; HUMANS; LIVER; MALE; MIDDLE AGED; PHOSPHOLIPIDS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SULFUR HEXAFLUORIDE; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY;

EID: 84896807862     PISSN: 18961126     EISSN: 18984002     Source Type: Journal    
DOI: 10.2478/ams-2013-0027     Document Type: Article

References (61)

1. Kammen BF, Pacharn P, Thoeni RF, Lu Y, Qayyum A, Coakly F, Gooding CA, Brasch RC. Focal fatty infiltration of the liver: analysis of prevalence and CT findings in children and young adults. AJR Am J Roentgenol. 2001 Nov;177(5):1035-9. (Pubitemid 32995534)
2. Mehta SR, Thomas EL, Bell JD, Johnston DG, Taylor-Robinson SD. Non-invasive means of measuring hepatic fat content. World J Gastroenterol. 2008 Jun;14(22):3476-83.
3. Preiss D, Sattar N. Non-alcoholic fatty liver disease: an overview of prevalence, diagnosis, pathogenesis and treatment considerations. Clin Sci (Lond). 2008 Sep;115(5):141-50.
4. Karcaaltincaba M, Akhan O. Imaging of hepatic steatosis and fatty sparing. Eur J Radiol. 2007 Jan;61(1):33-43. (Pubitemid 46038027)
5. Kemper J, Jung G, Poll LW, Jonkmanns C, Lüthen R, Moedder U. CT and MRI findings of multifocal hepatic steatosis mimicking malignancy. Abdom Imaging. 2002 Nov- Dec;27(6):708-10. (Pubitemid 36459354)
6. Rubaltelli L, Savastano S, Khadivi Y, Stramare R, Tregnaghi A, Da Pian P. Targetlike appearance of pseudotumors in segment IV of the liver on sonography. AJR Am J Roentgenol. 2002 Jan;178(1):75-7. (Pubitemid 34016373)
7. Wang WP, Ding H, Qi Q, Mao F, Xu ZZ, Kudo M. Characterization of focal hepatic lesions with contrastenhanced C-cube gray scale ultrasonography. World J Gastroenterol. 2003 Aug;9(8):1667-74. (Pubitemid 37038110)
8. White EM, Simeone JF, Mueller PR, Grant EG, Choyke PL, Zeman RK. Focal periportal sparing in hepatic fatty infiltration: a cause of hepatic pseudomass on US. Radiology. 1987 Jan;162(1 Pt 1):57-9. (Pubitemid 17001782)
9. Kim KW, Kim MJ, Lee SS, Kim HJ, Shin YM, Kim PN, Lee MG. Sparing of fatty infiltration around focal hepatic lesions in patients with hepatic steatosis: sonographic appearance with CT and MRI correlation. AJR Am J Roentgenol. 2008 Apr;190(4):1018-27. (Pubitemid 351571499)
10. Quaia E, D'Onofrio M, Palumbo A, Rossi S, Bruni S, Cova M. Comparison of contrast-enhanced ultrasonography versus baseline ultrasound and contrastenhanced computed tomography in metastatic disease of the liver: diagnostic performance and confidence. Eur Radiol. 2006 Jul;16(7):1599-609. (Pubitemid 43871833)
11. Catala V, Nicolau C, Vilana R, Pages M, Bianchi L, Sanchez M, Bru C. Characterization of focal liver lesions: comparative study of contrast-enhanced ultrasound versus spiral computed tomography. Eur Radiol. 2007 Apr;17(4):1066-73. (Pubitemid 46766888)
12. Gersema LM. Radiographic contrast media: an introduction to its use, adverse-effect profile, and economic impact. J Pharm Technol. 1993 Jan-Feb;9(1):18-24. (Pubitemid 23073680)
13. Gilgen-Anner Y, Heim M, Ledermann HP, Bircher AJ. Iodide mumps after contrast media imaging: a rare adverse effect to iodine. Ann Allergy Asthma Immunol. 2007 Jul;99(1):93-8. (Pubitemid 47075958)
14. Komeda Y, Kato H, Saito K, Morishita F, Mori Y. [Adverse effect of iodine contrast media]. Hinyokika Kiyo. 1987 Feb;33(2):183-6. Japanese. (Pubitemid 17039989)
15. Bartolotta TV, Midiri M, Galia M, Rollandi GA, Cademartiri F, Lagalla R, Cardinale AE. Characterization of benign hepatic tumors arising in fatty liver with SonoVue and pulse inversion US. Abdom Imaging. 2007 Jan- Feb;32(1):84-91. (Pubitemid 46742682)
16. Beaton C, Cochlin D, Kumar N. Contrast enhanced ultrasound should be the initial radiological investigation to characterise focal liver lesions. Eur J Surg Oncol. 2010 Jan;36(1):43-6.
17. Dietrich CF, Mertens JC, Braden B, Schuessler G, Ott M, Ignee A. Contrast-enhanced ultrasound of histologically proven liver hemangiomas. Hepatology. 2007 May;45(5):1139-45. (Pubitemid 46775775)
18. Janica JR, Lebkowska U, Ustymowicz A, Augustynowicz A, Kamocki Z, Werel D, Polaków J, Kedra B, Pepinski W. Contrast-enhanced ultrasonography in diagnosing liver metastases. Med Sci Monit. 2007 May;13 Suppl 1:111-5.
19. Li R, Guo Y, Hua X, He Y, Ding J, Guo A, Luo M. Characterization of focal liver lesions: comparison of pulse-inversion harmonic contrast-enhanced sonography with contrast-enhanced CT. J Clin Ultrasound. 2007 Mar- Apr;35(3):109-17. (Pubitemid 46697187)
20. Claudon M, Cosgrove D, Albrecht T, Bolondi L, Bosio M, Calliada F, Correas JM, Darge K, Dietrich C, D'Onofrio M, Evans DH, Filice C, Greiner L, Jäger K, Jong Nd, Leen E, Lencioni R, Lindsell D, Martegani A, Meairs S, Nolsøe C, Piscaglia F, Ricci P, Seidel G, Skjoldbye B, Solbiati L, Thorelius L, Tranquart F, Weskott HP, Whittingham T. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) - update 2008. Ultraschall Med. 2008 Feb;29(1):28-44. (Pubitemid 351294171)
21. von Herbay A, Westendorff J, Gregor M. Contrastenhanced ultrasound with SonoVue: differentiation between benign and malignant focal liver lesions in 317 patients. J Clin Ultrasound. 2010 Jan;38(1):1-9.
22. Wang ZL, Tang J, Weskott HP, Li JL, Wang W, Luo YK, An LC, Xu JH. Undetermined focal liver lesions on grayscale ultrasound in patients with fatty liver: characterization with contrast-enhanced ultrasound. J Gastroenterol Hepatol. 2008 Oct;23(10):1511-9.
23. Bartolotta TV, Midiri M, Quaia E, Bertolotto M, Galia M, Cademartiri F, Lagalla R. Liver haemangiomas undetermined at grey-scale ultrasound: contrast-enhancement patterns with SonoVue and pulse-inversion US. Eur Radiol. 2005 Apr;15(4):685-93.
24. Bertolotto M, Dalla Palma L, Quaia E, Locatelli M. Characterization of unifocal liver lesions with pulse inversion harmonic imaging after Levovist injection: preliminary results. Eur Radiol. 2000;10(9):1369-76.
25. von Herbay A, Haeussinger D, Gregor M, Vogt C. Characterization and detection of hepatocellular carcinoma (HCC): comparison of the ultrasound contrast agents SonoVue (BR 1) and Levovist (SH U 508A) - comparison of SonoVue and Levovist in HCC. Ultraschall Med. 2007 Apr;28(2):168-75. (Pubitemid 46732447)
26. Bokor D. Diagnostic efficacy of SonoVue. Am J Cardiol. 2000 Aug 17;86(4A):19G-24G. (Pubitemid 30645928)
27. Kim SH, Lee JM, Lee JY, Han JK, An SK, Han CJ, Lee KH, Hwang SS, Choi BI. Value of contrast-enhanced sonography for the characterization of focal hepatic lesions in patients with diffuse liver disease: receiver operating characteristic analysis. AJR Am J Roentgenol. 2005 Apr;184(4):1077-84. (Pubitemid 43821879)
28. Bokor D, Chambers JB, Rees PJ, Mant TG, Luzzani F, Spinazzi A. Clinical safety of SonoVue, a new contrast agent for ultrasound imaging, in healthy volunteers and in patients with chronic obstructive pulmonary disease. Invest Radiol. 2001 Feb;36(2):104-9. (Pubitemid 32147857)
29. Piscaglia F, Bolondi L; Italian Society for Ultrasound in Medicine and Biology (SIUMB) Study Group on Ultrasound Contrast Agents. The safety of Sonovue in abdominal applications: retrospective analysis of 23188 investigations. Ultrasound Med Biol. 2006 Sep;32(9):1369-75. (Pubitemid 44332662)
30. Strobel D, Bernatik T, Blank W, Schuler A, Greis C, Dietrich CF, Seitz K. Diagnostic accuracy of CEUS in the differential diagnosis of small (≤ 20 mm) and subcentimetric (≤ 10 mm) focal liver lesions in comparison with histology. Results of the DEGUM multicenter trial. Ultraschall Med. 2011 Dec;32(6):593-7.
31. Xie L, Guang Y, Ding H, Cai A, Huang Y. Diagnostic value of contrast-enhanced ultrasound, computed tomography and magnetic resonance imaging for focal liver lesions: a meta-analysis. Ultrasound Med Biol. 2011 Jun;37(6):854-61.
32. Clevert DA, Jung EM, Stock KF, Weckbach S, Feuerbach S, Reiser M, Jung F. Evaluation of malignant liver tumors: biphasic MS-CT versus quantitative contrast harmonic imaging ultrasound. Z Gastroenterol. 2009 Dec;47(12):1195-202.
33. Liu LP, Dong BW, Yu XL, Zhang DK, Li X, Li H. Analysis of focal spared areas in fatty liver using color Doppler imaging and contrast-enhanced microvessel display sonography. J Ultrasound Med. 2008 Mar;27(3):387-94. (Pubitemid 351428122)
34. Liu LP, Dong BW, Yu XL, Zhang DK, Kang CS, Zhao XH. Evaluation of focal fatty infiltration of the liver using color Doppler and contrast-enhanced sonography. J Clin Ultrasound. 2008 Nov-Dec;36(9):560-6.
35. Hamaguchi M, Kojima T, Itoh Y, Harano Y, Fujii K, Nakajima T, Kato T, Takeda N, Okuda J, Ida K, Kawahito Y, Yoshikawa T, Okanoue T. The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation. Am J Gastroenterol. 2007 Dec;102(12):2708-15. (Pubitemid 350179336)
36. Bismuth H. Surgical anatomy and anatomical surgery of the liver. World J Surg. 1982 Jan;6(1):3-9. (Pubitemid 12066476)
37. Mazhar SM, Shiehmorteza M, Sirlin CB. Noninvasive assessment of hepatic steatosis. Clin Gastroenterol Hepatol. 2009 Feb;7(2):135-40.
38. Joy D, Thava VR, Scott BB. Diagnosis of fatty liver disease: is biopsy necessary? Eur J Gastroenterol Hepatol. 2003 May;15(5):539-43. (Pubitemid 36571048)
39. Powell EE, Searle J, Mortimer R. Steatohepatitis associated with limb lipodystrophy. Gastroenterology. 1989 Oct;97(4):1022-4. (Pubitemid 19239045)
40. Grossholz M, Terrier F, Rubbia L, Becker C, Stoupis C, Hadengue A, Mentha G. Focal sparing in the fatty liver as a sign of an adjacent space-occupying lesion. AJR Am J Roentgenol. 1998 Nov;171(5):1391-5. (Pubitemid 28489436)
41. Diehl AM, Goodman Z, Ishak KG. Alcohollike liver disease in nonalcoholics. A clinical and histologic comparison with alcohol-induced liver injury. Gastroenterology. 1988 Oct;95(4):1056-62.
42. Wanless IR, Lentz JS. Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology. 1990 Nov;12(5):1106-10.
43. Van Steenbergen W, Lanckmans S. Liver disturbances in obesity and diabetes mellitus. Int J Obes Relat Metab Disord. 1995 Sep;19 Suppl 3:S27-36.
44. Graif M, Yanuka M, Baraz M, Blank A, Moshkovitz M, Kessler A, Gilat T, Weiss J, Walach E, Amazeen P, Irving CS. Quantitative estimation of attenuation in ultrasound video images: correlation with histology in diffuse liver disease. Invest Radiol. 2000 May;35(5):319-24. (Pubitemid 30395315)
45. Mathiesen UL, Franzén LE, Aselius H, Resjö M, Jacobsson L, Foberg U, Frydén A, Bodemar G. Increased liver echogenicity at ultrasound examination reflects degree of steatosis but not of fibrosis in asymptomatic patients with mild/moderate abnormalities of liver transaminases. Dig Liver Dis. 2002 Jul;34(7):516-22. (Pubitemid 34830694)
46. Jacobs JE, Birnbaum BA, Shapiro MA, Langlotz CP, Slosman F, Rubesin SE, Horii SC. Diagnostic criteria for fatty infiltration of the liver on contrast-enhanced helical CT. AJR Am J Roentgenol. 1998 Sep;171(3):659-64. (Pubitemid 28406126)
47. Ralls PW, Mack LA. Spectral and color Doppler sonography. Semin Ultrasound CT MR. 1992 Oct;13(5):355-66.
48. Wilson SR, Rosen IE, Chin-Sang HB, Arenson AM. Fatty infiltration of the liver - an imaging challenge. J Can Assoc Radiol. 1982 Dec;33(4):227-32. (Pubitemid 13068958)
49. Bartolotta TV, Sandonato L, Taibbi A, Latteri S, Soresi M, Lombardo G, Genova C, Latteri MA. [Focal liver lesions: clinical usefulness of contrast-enhanced ultrasound in the selection of surgical patients]. Chir Ital. 2009 May- Jun;61(3):295-307. Italian.
50. Kim KW, Kim AY, Kim TK, Kim SY, Kim MJ, Park MS, Park SH, Lee KH, Kim JK, Kim PN, Ha HK, Lee MG. Hepatic hemangiomas with arterioportal shunt: sonographic appearances with CT and MRI correlation. AJR Am J Roentgenol. 2006 Oct;187(4):W406-14.
51. Konno K, Ishida H, Sato M, Komatsuda T, Ishida J, Naganuma H, Hamashima Y, Watanabe S. Liver tumors in fatty liver: difficulty in ultrasonographic interpretation. Abdom Imaging. 2001 Sep-Oct;26(5):487-91. (Pubitemid 32803619)
52. Kawashima A, Suehiro S, Murayama S, Russell WJ. Focal fatty infiltration of the liver mimicking a tumor: sonographic and CT features. J Comput Assist Tomogr. 1986 Mar-Apr;10(2):329-31. (Pubitemid 16113421)
53. Dodds WJ, Erickson SJ, Taylor AJ, Lawson TL, Stewart ET. Caudate lobe of the liver: anatomy, embryology, and pathology. AJR Am J Roentgenol. 1990 Jan;154(1):87-93. (Pubitemid 20029651)
54. Chami L, Lassau N, Malka D, Ducreux M, Bidault S, Roche A, Elias D. Benefits of contrast-enhanced sonography for the detection of liver lesions: comparison with histologic findings. AJR Am J Roentgenol. 2008 Mar;190(3):683-90. (Pubitemid 351304512)
55. Wang WP, Wu Y, Luo Y, Li R, Zhou XD, Zhang J, Qian CW, Tan XY, Xu QH, Wang Y, Yuan JJ. Clinical value of contrast-enhanced ultrasonography in the characterization of focal liver lesions: a prospective multicenter trial. Hepatobiliary Pancreat Dis Int. 2009 Aug;8(4):370-6.
56. Ooi CC, Low SC, Schneider-Kolsky M, Lombardo P, Lim SY, Abu Bakar R, Lo RH. Diagnostic accuracy of contrast-enhanced ultrasound in differentiating benign and malignant focal liver lesions: a retrospective study. J Med Imaging Radiat Oncol. 2010 Oct;54(5):421-30.
57. Liu GJ, Wang W, Xie XY, Xu HX, Xu ZF, Zheng YL, Liang JY, Moriyasu F, Lu MD. Real-time contrast- enhanced ultrasound imaging of focal liver lesions in fatty liver. Clin Imaging. 2010 May-Jun;34(3):211-21.
58. Lencioni R. European federation of societies for ultrasound in medicine and biology (EFSUMB) guidelines for the use of contrast agents in liver ultrasound: what is the impact in clinical practice? Eur Radiol. 2005 Dec;15 Suppl 5:E98-103.
59. Itai Y, Maeda M, Echigo J, Pan X, Saida Y, Kurosaki Y, Arai Y. Hyperattenuating rim on noncontrast CT of the liver: probable peritumoral sparing of fatty infiltration. Clin Radiol. 1996 Jun;51(6):406-10.
60. Faccioli N, D'Onofrio M, Comai A, Cugini C. Contrast-enhanced ultrasonography in the characterization of benign focal liver lesions: activity-based cost analysis. Radiol Med. 2007 Sep;112(6):810-20. (Pubitemid 350155015)
61. Liu P, Wang X, Zhou S, Hua X, Liu Z, Gao Y. Effects of a novel ultrasound contrast agent with long persistence on right ventricular pressure: Comparison with SonoVue. Ultrasonics. 2011 Feb;51(2):210-4.